Effect of Human Donor Cell Source on Differentiation and Function of Cardiac Induced Pluripotent Stem Cells

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

卷:64

Article

Sanchez-Freire, Veronica^1,2,3,4  Lee, Andrew S.^1,2,4  Hu, Shijun^1,2,4  Abilez, Oscar J.²  Liang, Ping^1,2,3  Lan, Feng^1,2,3  Huber, Bruno C.^1,2  Ong, Sang-Ging^1,2,3  Hong, Wan Xing^1,2,4  Huang, Mei^1,2,3  Wu, Joseph C.^1,2,3,4 

[1] Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA 94305 USA

[2] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA

[3] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA

[4] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA

关键词: cardiac differentiation;    DNA methylation;    epigenetic memory;    pluripotent stem cells;   

DOI  :  10.1016/j.jacc.2014.04.056

来源: Elsevier

【 摘 要 】

BACKGROUND Human-induced pluripotent stem cells (iPSCs) are a potentially unlimited source for generation of cardiomyocytes (iPSC-CMs). However, current protocols for iPSC-CM derivation face several challenges, including variability in somatic cell sources and inconsistencies in cardiac differentiation efficiency. OBJECTIVES This study aimed to assess the effect of epigenetic memory on differentiation and function of iPSC-CMs generated from somatic cell sources of cardiac versus noncardiac origins. METHODS Cardiac progenitor cells (CPCs) and skin fibroblasts from the same donors were reprogrammed into iPSCs and differentiated into iPSC-CMs via embryoid body and monolayer-based differentiation protocols. RESULTS Differentiation efficiency was found to be higher in CPC-derived iPSC-CMs (CPC-iPSC-CMs) than in fibroblast-derived iPSC-CMs (Fib-iPSC-CMs). Gene expression analysis during cardiac differentiation demonstrated up-regulation of cardiac transcription factors in CPC-iPSC-CMs, including NKX2-5, MESP1, ISL1, HAND2, MYOCD, MEF2C, and GATA4. Epigenetic assessment revealed higher methylation in the promoter region of NKX2-5 in Fib-iPSC-CMs compared with CPC-iPSC-CMs. Epigenetic differences were found to dissipate with increased cell passaging, and a battery of in vitro assays revealed no significant differences in their morphological and electrophysiological properties at early passage. Finally, cell delivery into a small animal myocardial infarction model indicated that CPC-iPSC-CMs and Fib-iPSC-CMs possess comparable therapeutic capabilities in improving functional recovery in vivo. CONCLUSIONS This is the first study to compare differentiation of iPSC-CMs from human CPCs versus human fibroblasts from the same donors. The authors demonstrate that although epigenetic memory improves differentiation efficiency of cardiac versus noncardiac somatic cell sources in vitro, it does not contribute to improved functional outcome in vivo. (C) 2014 by the American College of Cardiology Foundation.

【 授权许可】

Free